Authors
Alja J Stel, Bram Ten Cate, Susan Jacobs, Jan Willem Kok, Diana CJ Spierings, Monica Dondorff, Wijnand Helfrich, Hanneke C Kluin-Nelemans, Lou FMH de Leij, Sebo Withoff, Bart Jan Kroesen
Publication date
2007/2/15
Journal
The Journal of Immunology
Volume
178
Issue
4
Pages
2287-2295
Publisher
American Association of Immunologists
Description
Ab binding to CD20 has been shown to induce apoptosis in B cells. In this study, we demonstrate that rituximab sensitizes lymphoma B cells to Fas-induced apoptosis in a caspase-8-dependent manner. To elucidate the mechanism by which Rituximab affects Fas-mediated cell death, we investigated rituximab-induced signaling and apoptosis pathways. Rituximab-induced apoptosis involved the death receptor pathway and proceeded in a caspase-8-dependent manner. Ectopic overexpression of FLIP (the physiological inhibitor of the death receptor pathway) or application of zIETD-fmk (specific inhibitor of caspase-8, the initiator-caspase of the death receptor pathway) both specifically reduced rituximab-induced apoptosis in Ramos B cells. Blocking the death receptor ligands Fas ligand or TRAIL, using neutralizing Abs, did not inhibit apoptosis, implying that a direct death receptor/ligand interaction is not involved …
Total citations
2007200820092010201120122013201420152016201720182019202020212022202339713137107774146321